Tyler J Mouw
Overview
Explore the profile of Tyler J Mouw including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
13
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cooney O, Goodin D, Mouw T, Martin R, Frieboes H
J Gastrointest Oncol
. 2024 Sep;
15(4):1847-1860.
PMID: 39279970
Background: Hyperthermic intraperitoneal chemotherapy (HIPEC) targets intraperitoneal tumors with heated drug solutions via catheters inserted into the peritoneal space. Although studies have focused on clinical outcomes, the flow dynamics at...
2.
Fromer M, Mouw T, Scoggins C, Egger M, Philips P, McMasters K, et al.
J Surg Oncol
. 2024 Jun;
130(2):284-292.
PMID: 38828742
Background: Neoadjuvant chemotherapy (NAC) use for pancreatic ductal adenocarcinoma (PDAC) has increased, but some patients never get resection following NAC. Methods: Data from January 2012 to December 2019 for all...
3.
Fromer M, Xu Q, Shindorf M, Mouw T, Kong M, Myers J, et al.
Am Surg
. 2024 Jan;
90(6):1195-1201.
PMID: 38205662
Background: Previous studies evaluating whether recent cholecystectomy is associated with a pancreas cancer diagnosis are limited. We aimed to examine if cholecystectomy was performed more frequently in the year prior...
4.
Morse R, Mouw T, Moreno M, Erwin J, Cao Y, DiPasco P, et al.
J Gastrointest Surg
. 2023 Mar;
27(7):1313-1320.
PMID: 36973500
Background: Esophagectomy is a complex oncologic surgery that results in lower perioperative morbidity and mortality when performed in high-volume hospitals by experienced surgeons; however, limited data exists evaluating the importance...
5.
Senders Z, Bartlett E, Mouw T, McMasters K, Egger M
Ann Surg Oncol
. 2023 Mar;
30(6):3648-3654.
PMID: 36934378
Introduction: Completion lymph node dissection (CLND) is no longer recommended routinely in the treatment of melanoma. CLND omission may understage patients for whom the distinction between stage IIIA and IIIB-C...
6.
Mouw T, Senders Z, Philips P, Scoggins C, Egger M, Al-Kasspooles M, et al.
Surgery
. 2022 Oct;
173(3):590-597.
PMID: 36243569
Background: Debate persists regarding the need for shaking during hyperthermic intraperitoneal chemotherapy. Studies assessing the thermal behaviors of the perfusate throughout the abdomen during hyperthermic intraperitoneal chemotherapy are limited. Methods:...
7.
Mouw T, Scoggins C
Hepatobiliary Surg Nutr
. 2021 Aug;
10(4):573-574.
PMID: 34430548
No abstract available.
8.
Mouw T, Lu J, Woody-Fowler M, Ashcraft J, Valentino J, DiPasco P, et al.
J Gastrointest Oncol
. 2018 Dec;
9(5):828-832.
PMID: 30505581
Background: Liver resection in conjunction with partial colectomy for colon cancer is considered acceptable treatment for isolated metastasis to the liver. This method is unstudied in patients undergoing cytoreductive surgery...
9.
Mouw T, Hong S, Sarwar S, Fondaw A, Walling A, Al-Kasspooles M, et al.
J Surg Res
. 2018 May;
227:151-157.
PMID: 29804847
Background: It has been previously reported that over 20% of surgical trials will be discontinued prematurely raising ethical and financial concerns. Previous studies have been limited in scope owing to...